Pollack, LA, Srinivasan, A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis 2014;59(Suppl 3):S97–S100.
Jenkins, TC, Knepper, BC, Sabel, AL, et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch Intern Med 2011;171:1072–1079.
Jenkins, TC, Stella, SA, Cervantes, L, et al. Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations. Infection 2013;41:135–144.
Spellberg, B. The new antibiotic mantra “shorter is better.” JAMA Intern Med 2016;176:1254–1255.
Hayashi, Y, Paterson, DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Di. 2011;52:1232–1240.
Tamma, PD, Avdic, E, Keenan, JF, et al. What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback? Clin Infect Dis 2017;64:537–543.
Yogo, N, Haas, MK, Knepper, BC, Burman, WJ, Mehler, PS, Jenkins, TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol 2015;36:474–478.
Moehring, RW, Anderson, DJ, Cochran, RL, et al. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings. Clin Infect Dis 2017;64:377–383.
Polk, RE, Hohmann, SF, Medvedev, S, Ibrahim, O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:1100–1110.
Ibrahim, OM, Polk, RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195–214.
Osterberg, L, Blaschke, T. Adherence to medication. N Engl J Med 2005;353:487–497.
Scarpato, SJ, Timko, DR, Cluzet, VC, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol 2017;38:353–355.
Uranga, A, Espana, PP, Bilbao, A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med 2016;176:1257–1265.
Chastre, J, Wolff, M, Fagon, JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588–2598.
Singh, N, Rogers, P, Atwood, CW, Wagener, MM, Yu, VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.
El Moussaoui, R, de Borgie, CA, van den Broek, P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community-acquired pneumonia: randomised, double-blind study. BMJ 2006;332(7554):1355.
Dunbar, LM, Wunderink, RG, Habib, MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37:752–760.
Eliakim-Raz, N, Yahav, D, Paul, M, Leibovici, L. Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection—7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2013;68:2183–2191.
Sawyer, RG, Claridge, JA, Nathens, AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;372:1996–2005.
Hepburn, MJ, Dooley, DP, Skidmore, PJ, Ellis, MW, Starnes, WF, Hasewinkle, WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 2004;164:1669–1674.
Yi, SH, Hatfield, KM, Baggs, J, et al. Duration of antibiotic use among adults with uncomplicated community-acquired pneumonia requiring hospitalization in the United States. Clin Infect Dis 2018;66:1333–1341.
Vaughn, VM, Gandhi, T, Conlon, A, Chopra, V, Malani, AN, Flanders, SA. The association of antibiotic stewardship with fluoroquinolone prescribing in Michigan hospitals: a multi-hospital cohort study. Clin Infect Dis 2019 Feb 13. doi: 10.1093/cid/ciy1102. [Epub ahead of print].
Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51–e77.
Pepin, J, Saheb, N, Coulombe, MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile–associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254–1260.
Avdic, E, Cushinotto, LA, Hughes, AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012;54:1581–1587.
Chua, KP, Fischer, MA, Linder, JA. Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM–based cross-sectional study. BMJ 2019;364:k5092.
Shrestha, N, Bhaskaran, A, Scalera, NM, et al. Antimicrobial stewardship at transition of care from hospital to community. Infect Cont Hosp Epidemiol 2012;33:401–404.
Meeker, D, Linder, JA, Fox, CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562–570.
Bork, JT, Morgan, DJ, Heil, EL, Pineles, L, Kleinberg, M. Peer comparison of anti-MRSA agent prescription in the inpatient setting. Infect Control Hosp Epidemiol 2017;38:1506–1508.